This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

HL009

HanAll Biopharma Co., Ltd.

Drug Names(s): HL-009, adenosylcobalamin liposomal gel

Description: HL009 is a topical gel nanoliposome formulation of vitamin B12 (adenosylcobalamin).

HL009 can bind to nitric oxide (NO), inhibit inducible nitric oxide synthase (iNOS) to further reduce NO levels, and activate T regulatory cells which excrete IL-10 and TGF-beta suppressing immune response.


HL009 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug